|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 733.5 USD | +1.19% |
|
+0.99% | +25.83% |
| 07:21am | Habeck's 'pharma trip' - industry sees structural problems | DP |
| Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
Dec 4 (Reuters) - Eli Lilly on Monday extended the deadline for the third time for Point Biopharma Global shareholders to sell their stock, due to low participation.
The new deadline is Dec. 15. (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 661B | |
| +26.82% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.68% | 231B | |
| +5.07% | 200B | |
| -9.16% | 195B | |
| -6.26% | 145B | |
| -11.77% | 144B |
ELI LILLY AND COMPANY 
